BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 20, 2022
J&J Beats Q1 Earnings Expectations, Announces Dividend Increase After… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
BIG PHARMA WATCH: BRANDED DRUG COMPANIES MORE THAN DOUBLED PRICES FOR BLOCKBUSTER BLOOD THINNING MEDICATIONS OVER TEN YEARS
Apr 7, 2022
New Report Demonstrates How Brand Name Drug Companies Work in “Lockstep”… Read More
DOSE OF REALITY: NEW STUDY FINDS ONE THIRD OF SENIORS DO NOT FILL PRESCRIPTIONS FOR HIGH-PRICE DRUGS USED TO TREAT SERIOUS CONDITIONS
Apr 6, 2022
Academic Study Underscores How Big Pharma’s Price-Gouging on Treatments for… Read More
THEY SAID IT! FINANCE COMMITTEE HIGHLIGHTS URGENCY TO HOLD BIG PHARMA ACCOUNTABLE FOR PRICE HIKES AND ANTI-COMPETITIVE BEHAVIOR
Mar 17, 2022
Lawmakers Double-Down on Repeated Promises to the American People to Lower… Read More
DOSE OF REALITY: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE IN SENATE FINANCE HEARING
Mar 14, 2022
Congress Can Refocus Attention on Market-Based Solutions to Crack Down on… Read More
BIG PHARMA WATCH: STUDY FINDS DRUG COMPANIES HIKED PRICES FASTER THAN INFLATION ON 23 OF TOP 25 MOST POPULAR MEDICARE PART D DRUGS
Feb 28, 2022
KFF Analysis Shows Big Pharma’s Price Hikes Outpaced Inflation for Half of… Read More
BIG PHARMA EARNINGS WATCH: MERCK, ELI LILLY, AMGEN, PFIZER, GLAXOSMITHKLINE, ASTRAZENECA
Feb 18, 2022
New Earnings Reports Show Big Pharma Giants Continue to Reap Massive Profits,… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, SANOFI, BRISTOL-MYERS SQUIBB, NOVARTIS
Feb 11, 2022
New Q4 Earnings Reports Underscore How Big Pharma’s Pandemic Price Hikes,… Read More
SECOND OPINION: PHRMA STUDY REHASHES DEBUNKED SUPPLY CHAIN BLAME GAMES
Feb 3, 2022
Big Pharma Sidesteps Industry’s Own Price Hikes and Egregious Practices in… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jan 28, 2022
J&J Surpasses Wall Street Expectations, Nearly Tripling Year-Over-Year… Read More
DOSE OF REALITY: NEW ANALYSIS UNDERSCORES HOW OFTEN BIG PHARMA’S PATENTS ARE UNRELATED TO CLINICAL INNOVATION
Jan 19, 2022
Study Finds Just Six Percent of Drug Patents in Infringement Suits Were for… Read More
SECOND OPINION: BIG PHARMA CEO CLAIMS “COURAGEOUS” TO PRICE UNPROVEN TREATMENT 10 TIMES ESTIMATE OF FAIR PRICE
Jan 11, 2022
Biogen Decision to Change Aduhelm Price After Public Outcry Demonstrates Big… Read More